This website uses cookies to enhance the user experience.
||
K

KRUUSE NORGE AS981 389 115

Purchase and sale
Limited company
c/o Ecit Råd & Regnskap AS Seiersten Sentrum 3 1443 DRØBAK, Norge
Goods and trade
/ Purchase and sale
/ 46.460 Wholesale of pharmaceutical goods

KRUUSE NORGE AS

Operating
Handel med artikler til dyr samt hva hermed står i forbindelse, samt investeringsvirksomhet av enhver art, herunder kjøp av fast eiendom og deltakelse i andre selskaper.
Handel med artikler til dyr, veterinærartikler

Keywords

pharmaceuticalshospital equipmentorthopedic articles

Organization

CEO
JP

Jesper Poulsen1985

Chairman of the board
MB

Mads Bonne Alkærsig1974

Years since formation
27 years
since Dec 22, 1999
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
10
1 share class
Total number of shareholders
1
person

Financials

Total operating income 2024
122,157,105
NOK
Annual total result 2024
4,319,000
NOK
Total equity 2024
18,771,543
NOK
Last update: Dec 12, 2025

Management

Management / administration

NameRoleShares
JP

Jesper Poulsen

1985

Managing Director/CEO-

Board

NameRoleShares
MB

Mads Bonne Alkærsig

1974

Chairman-

Others

NameRoleShares
B
BDO AS
Auditor-
E
ECIT SERVICES AS
Accountant-
Last update: Aug 26, 2025

Ownership

Company shareholders

NameShare classTotal number of sharesShare
JK

Jørgen Kruuse As

Ordinary shares
10
100 %
Last update: Jun 2, 2025

Financials

in NOK

Summary

Year2024202320222021
Total operating income
122,157,105
115,536,641
55,676,232
60,822,966
Annual Total Result
4,319,000
4,051,058
1,857,966
1,759,724
Total assets
27,793,075
27,091,442
17,342,387
26,528,338
Total liabilities
9,021,533
12,638,899
6,940,902
17,984,820
Total equity
18,771,543
14,452,543
10,401,485
8,543,519

P&L

Year2024202320222021
Total operating income
122,157,105
115,536,641
55,676,232
60,822,966
Total operating costs
116,926,617
110,442,267
53,291,150
58,622,957
Operating result
5,230,487
5,094,374
2,385,082
2,200,009
Financial income/costs
313,305
103,336
5,587
62,512
Profit before tax
5,543,793
5,197,710
2,390,669
2,262,521
Total tax & extraordinary income/cost
1,224,793
1,146,652
532,703
502,797
Annual Total Result
4,319,000
4,051,058
1,857,966
1,759,724

Balance overview

Year2024202320222021
Total fixed assets
314,059
315,922
196,378
201,211
Total current assets
27,479,016
26,775,520
17,146,009
26,327,127
Total assets
27,793,075
27,091,442
17,342,387
26,528,338
Short term debt
9,021,533
12,638,899
6,940,902
17,984,820
Long term debt
0
0
0
0
Total liabilities
9,021,533
12,638,899
6,940,902
17,984,820
Contributed capital
1,100,000
1,100,000
1,100,000
1,100,000
Retained earnings
17,671,543
13,352,543
9,301,485
7,443,519
Total equity
18,771,543
14,452,543
10,401,485
8,543,519
Total equity and liabilities
27,793,075
27,091,442
17,342,387
26,528,338

Classification

21st company classification
BETA
Industrial large enterprise
Category
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises
Standard industrial classification
G
Main industrial area
Wholesale and retail trade; repair of motor vehicles and motorcycles
46
Activity
Wholesale trade, except of motor vehicles and motorcycles
46.4
Main industrial group
Wholesale of household goods
46.46
Industrial group
Wholesale of pharmaceutical goods
46.460
Industrial group
Wholesale of pharmaceutical goods